Sudoscan demonstration tutorial

SUDOSCAN the two minute sudomotorfunction test SUDOSCAN is an FDA cleared medicaldevice that measure sweat gland function as an indior for small fiberperipheral neuropathy. The test does not require specialized training, preparationor certifiion and only takes two minutes to perform The patient is asked to put his handsand feet on the stainless steel sensor plates. Tthey must be centered on the platefor maximum skin to electrode contact Movement must be avoided

and the patient must not be touchedduring the scan. The patient's name, ID, age, genderweight and height are typed into the analyzer. The test starts when the scanbutton is pressed. As the test starts, the sensor platesauto calibrate and a small direct current of less than four Volts isapplied to both the hand and foot sensor plates. The chloride ions from the sweatglands are attracted to the stainless steel plates The chloride conductance is quantified andacts as a biomarker to assess sweat gland

functionrelation to small nervestructure SUDOSCAN can distinguish between asymmetric and symmetric small nerve fibre damaged by swapping electrodepolarity during scanning thus allowing SUDOSCAN todifferentiate between an isolated unilateral peripheral neuropathy anda peripheral autonomic neuropathy. A double beep indies that the scan is complete. Thepatients report is automatically generated

The measured conductances are expressedmicro siemens. A conductance of greater than or equal tosixty micro siemens indies good sweat function, a conductance between fourtyand sixty micro siemens indies moderate sweat function and suggestpossible early signs of peripheral autonomic neuropathy. A conductance of less than or equal tofourty micro siemens indies poor sweat function and suggest possible advancedperipheral autonomic neuropathy. The amount of observed asymmetry is anindior of the type of peripheral

neuropathy. For example symmetrical peripheralneuropathy would be consistent with either a pre diabetic or diabeticcompliion. Followup schedules are determined bythe patient's SUDOSCAN conductance level and the asymmetry observed betweenthe left and right sides. A patient with poor sweat function andor high asymmetry should receive medical evaluation and is encouraged toretestthree months. A patient with good sweat function and low asymmetrycan proactively retest within six to

nine months for preventative monitoring. SUDOSCAN is an innovative and easy touse medical device. The test is fast, quantitative, reproducible, noninvasiveand doesn't require any patient preparation for more information pleasefeel free to contact your local Imo Medical representative.

SudoscanPlus demonstration tutorial

SUDOSCAN+ Early detection of diabetescompliions. SUDOSCAN+ is a CE certified device that measuressweat gland function as an indior for small fiberperipheral neuropathydiabetic patients The test does not require specifictraining, preparation or certifiion and only takes two minutes to perform. The patient is asked to put his handsand feet on the stainless steel

electrode plates. They must be centered on the plate for maximum skin to electrode contact.Movement must be avoided and the subject must not be touchedduring the scan. The patient's name or ID, age, gender, weight and height are typed into the analyzer.The test starts when the scan button is pressed.

As the test starts the electrodes lightup and a small direct current of less thanfour volts is applied to both the hand and footelectrodes. The chloride ions from the sweat glandsare attracted to the stainless steel plates. The chloride conductance measuredacts as a biomarker to assess sweat functionrelation to small nervestructure. SUDOSCAN+ can distinguish between asymmetric orsymmetric small nerve fibre damage by swapping electrode polarity duringscanning. Thus SUDOSCAN+

distinguishes between unilateral nervedamage caused by bilateral peripheral polyneuropathy or autonomic dysfunction. A double beepindies that the scan is complete. The patient report is automaticallygenerated. The measured conductances are expressedin micro siemens and a cardiovascular neuropathy risk score is calculated andexpressedpercentage value. A conductance of sixty or greaterindies good sweat function and no peripheral neuropathy.

A conductance of between fourty and sixty indies moderates sweat function andmoderate neuropathy. A conductance of fourty or less indies poor sweat functionand peripheral neuropathy. A cardiovascular neuropathy risk scorethat is lower than twenty five percent indies low risk. A score between twenty five and fiftypercent indies moderate risk. A score of fifty percent or higherindies high risk. the amount of observed asymmetry is anindior of the kind of autonomic

dysfunction. Symmetrical peripheralneuropathy would be consistent with diabeticcompliion. Followup schedules are determined bythe patient's SUDOSCAN+ results and observed asymmetry between left anight sides. A patient with a poor sweat function and or high asymetry isencouraged to retestthe near future. A patient with good sweat function andlow asymmetry may only require retesting on an annualor semi annual basis for preventative monitoring.